img

Global Health Product for Immune Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Health Product for Immune Market Insights, Forecast to 2034

The global Health Product for Immune market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Health Product for Immune is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Health Product for Immune is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Health Product for Immune is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Health Product for Immune include Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, USANA Health Sciences, Inc., PERFECT, Nestlé SA and H&H Group, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Health Product for Immune, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Health Product for Immune, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Health Product for Immune, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Health Product for Immune sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Health Product for Immune market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Health Product for Immune sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, USANA Health Sciences, Inc., PERFECT, Nestlé SA and H&H Group, etc.



By Company


Amway
Suntory
GNC
INFINITUS
Herbalife Nutrition
USANA Health Sciences, Inc.
PERFECT
Nestlé SA
H&H Group
China New Era Group
By-health
Black Mores
Glanbia Plc
Nature’s
Real Nutriceutical
Segment by Type
Capsule/Pills
Powder
Liquid

Segment by Application


Children/Teenagers
Men
Adults
The Elderly

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Health Product for Immune in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Health Product for Immune manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Health Product for Immune sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Health Product for Immune Product Introduction
1.2 Market by Type
1.2.1 Global Health Product for Immune Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Capsule/Pills
1.2.3 Powder
1.2.4 Liquid
1.3 Market by Application
1.3.1 Global Health Product for Immune Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Children/Teenagers
1.3.3 Men
1.3.4 Adults
1.3.5 The Elderly
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Health Product for Immune Sales Estimates and Forecasts 2018-2034
2.2 Global Health Product for Immune Revenue by Region
2.2.1 Global Health Product for Immune Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Health Product for Immune Revenue by Region (2018-2024)
2.2.3 Global Health Product for Immune Revenue by Region (2024-2034)
2.2.4 Global Health Product for Immune Revenue Market Share by Region (2018-2034)
2.3 Global Health Product for Immune Sales Estimates and Forecasts 2018-2034
2.4 Global Health Product for Immune Sales by Region
2.4.1 Global Health Product for Immune Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Health Product for Immune Sales by Region (2018-2024)
2.4.3 Global Health Product for Immune Sales by Region (2024-2034)
2.4.4 Global Health Product for Immune Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Health Product for Immune Sales by Manufacturers
3.1.1 Global Health Product for Immune Sales by Manufacturers (2018-2024)
3.1.2 Global Health Product for Immune Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Health Product for Immune in 2022
3.2 Global Health Product for Immune Revenue by Manufacturers
3.2.1 Global Health Product for Immune Revenue by Manufacturers (2018-2024)
3.2.2 Global Health Product for Immune Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Health Product for Immune Revenue in 2022
3.3 Global Key Players of Health Product for Immune, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Health Product for Immune Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Health Product for Immune Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Health Product for Immune, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Health Product for Immune, Product Offered and Application
3.8 Global Key Manufacturers of Health Product for Immune, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Health Product for Immune Sales by Type
4.1.1 Global Health Product for Immune Historical Sales by Type (2018-2024)
4.1.2 Global Health Product for Immune Forecasted Sales by Type (2024-2034)
4.1.3 Global Health Product for Immune Sales Market Share by Type (2018-2034)
4.2 Global Health Product for Immune Revenue by Type
4.2.1 Global Health Product for Immune Historical Revenue by Type (2018-2024)
4.2.2 Global Health Product for Immune Forecasted Revenue by Type (2024-2034)
4.2.3 Global Health Product for Immune Revenue Market Share by Type (2018-2034)
4.3 Global Health Product for Immune Price by Type
4.3.1 Global Health Product for Immune Price by Type (2018-2024)
4.3.2 Global Health Product for Immune Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Health Product for Immune Sales by Application
5.1.1 Global Health Product for Immune Historical Sales by Application (2018-2024)
5.1.2 Global Health Product for Immune Forecasted Sales by Application (2024-2034)
5.1.3 Global Health Product for Immune Sales Market Share by Application (2018-2034)
5.2 Global Health Product for Immune Revenue by Application
5.2.1 Global Health Product for Immune Historical Revenue by Application (2018-2024)
5.2.2 Global Health Product for Immune Forecasted Revenue by Application (2024-2034)
5.2.3 Global Health Product for Immune Revenue Market Share by Application (2018-2034)
5.3 Global Health Product for Immune Price by Application
5.3.1 Global Health Product for Immune Price by Application (2018-2024)
5.3.2 Global Health Product for Immune Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Health Product for Immune Market Size by Type
6.1.1 US & Canada Health Product for Immune Sales by Type (2018-2034)
6.1.2 US & Canada Health Product for Immune Revenue by Type (2018-2034)
6.2 US & Canada Health Product for Immune Market Size by Application
6.2.1 US & Canada Health Product for Immune Sales by Application (2018-2034)
6.2.2 US & Canada Health Product for Immune Revenue by Application (2018-2034)
6.3 US & Canada Health Product for Immune Market Size by Country
6.3.1 US & Canada Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Health Product for Immune Sales by Country (2018-2034)
6.3.3 US & Canada Health Product for Immune Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Health Product for Immune Market Size by Type
7.1.1 Europe Health Product for Immune Sales by Type (2018-2034)
7.1.2 Europe Health Product for Immune Revenue by Type (2018-2034)
7.2 Europe Health Product for Immune Market Size by Application
7.2.1 Europe Health Product for Immune Sales by Application (2018-2034)
7.2.2 Europe Health Product for Immune Revenue by Application (2018-2034)
7.3 Europe Health Product for Immune Market Size by Country
7.3.1 Europe Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Health Product for Immune Sales by Country (2018-2034)
7.3.3 Europe Health Product for Immune Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Health Product for Immune Market Size
8.1.1 China Health Product for Immune Sales (2018-2034)
8.1.2 China Health Product for Immune Revenue (2018-2034)
8.2 China Health Product for Immune Market Size by Application
8.2.1 China Health Product for Immune Sales by Application (2018-2034)
8.2.2 China Health Product for Immune Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Health Product for Immune Market Size by Type
9.1.1 Asia Health Product for Immune Sales by Type (2018-2034)
9.1.2 Asia Health Product for Immune Revenue by Type (2018-2034)
9.2 Asia Health Product for Immune Market Size by Application
9.2.1 Asia Health Product for Immune Sales by Application (2018-2034)
9.2.2 Asia Health Product for Immune Revenue by Application (2018-2034)
9.3 Asia Health Product for Immune Sales by Region
9.3.1 Asia Health Product for Immune Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Health Product for Immune Revenue by Region (2018-2034)
9.3.3 Asia Health Product for Immune Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Health Product for Immune Market Size by Type
10.1.1 Middle East, Africa and Latin America Health Product for Immune Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Health Product for Immune Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Health Product for Immune Market Size by Application
10.2.1 Middle East, Africa and Latin America Health Product for Immune Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Health Product for Immune Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Health Product for Immune Sales by Country
10.3.1 Middle East, Africa and Latin America Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Health Product for Immune Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Health Product for Immune Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Amway
11.1.1 Amway Company Information
11.1.2 Amway Overview
11.1.3 Amway Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Amway Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amway Recent Developments
11.2 Suntory
11.2.1 Suntory Company Information
11.2.2 Suntory Overview
11.2.3 Suntory Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Suntory Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Suntory Recent Developments
11.3 GNC
11.3.1 GNC Company Information
11.3.2 GNC Overview
11.3.3 GNC Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GNC Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GNC Recent Developments
11.4 INFINITUS
11.4.1 INFINITUS Company Information
11.4.2 INFINITUS Overview
11.4.3 INFINITUS Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 INFINITUS Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 INFINITUS Recent Developments
11.5 Herbalife Nutrition
11.5.1 Herbalife Nutrition Company Information
11.5.2 Herbalife Nutrition Overview
11.5.3 Herbalife Nutrition Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Herbalife Nutrition Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Herbalife Nutrition Recent Developments
11.6 USANA Health Sciences, Inc.
11.6.1 USANA Health Sciences, Inc. Company Information
11.6.2 USANA Health Sciences, Inc. Overview
11.6.3 USANA Health Sciences, Inc. Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 USANA Health Sciences, Inc. Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 USANA Health Sciences, Inc. Recent Developments
11.7 PERFECT
11.7.1 PERFECT Company Information
11.7.2 PERFECT Overview
11.7.3 PERFECT Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 PERFECT Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PERFECT Recent Developments
11.8 Nestlé SA
11.8.1 Nestlé SA Company Information
11.8.2 Nestlé SA Overview
11.8.3 Nestlé SA Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Nestlé SA Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nestlé SA Recent Developments
11.9 H&H Group
11.9.1 H&H Group Company Information
11.9.2 H&H Group Overview
11.9.3 H&H Group Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 H&H Group Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 H&H Group Recent Developments
11.10 China New Era Group
11.10.1 China New Era Group Company Information
11.10.2 China New Era Group Overview
11.10.3 China New Era Group Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 China New Era Group Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 China New Era Group Recent Developments
11.11 By-health
11.11.1 By-health Company Information
11.11.2 By-health Overview
11.11.3 By-health Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 By-health Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 By-health Recent Developments
11.12 Black Mores
11.12.1 Black Mores Company Information
11.12.2 Black Mores Overview
11.12.3 Black Mores Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Black Mores Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Black Mores Recent Developments
11.13 Glanbia Plc
11.13.1 Glanbia Plc Company Information
11.13.2 Glanbia Plc Overview
11.13.3 Glanbia Plc Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Glanbia Plc Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Glanbia Plc Recent Developments
11.14 Nature’s
11.14.1 Nature’s Company Information
11.14.2 Nature’s Overview
11.14.3 Nature’s Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Nature’s Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Nature’s Recent Developments
11.15 Real Nutriceutical
11.15.1 Real Nutriceutical Company Information
11.15.2 Real Nutriceutical Overview
11.15.3 Real Nutriceutical Health Product for Immune Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Real Nutriceutical Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Real Nutriceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Health Product for Immune Industry Chain Analysis
12.2 Health Product for Immune Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Health Product for Immune Production Mode & Process
12.4 Health Product for Immune Sales and Marketing
12.4.1 Health Product for Immune Sales Channels
12.4.2 Health Product for Immune Distributors
12.5 Health Product for Immune Customers
13 Market Dynamics
13.1 Health Product for Immune Industry Trends
13.2 Health Product for Immune Market Drivers
13.3 Health Product for Immune Market Challenges
13.4 Health Product for Immune Market Restraints
14 Key Findings in The Global Health Product for Immune Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Health Product for Immune Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Capsule/Pills
Table 3. Major Manufacturers of Powder
Table 4. Major Manufacturers of Liquid
Table 5. Global Health Product for Immune Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Health Product for Immune Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Health Product for Immune Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Health Product for Immune Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Health Product for Immune Revenue Market Share by Region (2018-2024)
Table 10. Global Health Product for Immune Revenue Market Share by Region (2024-2034)
Table 11. Global Health Product for Immune Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 12. Global Health Product for Immune Sales by Region (2018-2024) & (K Units)
Table 13. Global Health Product for Immune Sales by Region (2024-2034) & (K Units)
Table 14. Global Health Product for Immune Sales Market Share by Region (2018-2024)
Table 15. Global Health Product for Immune Sales Market Share by Region (2024-2034)
Table 16. Global Health Product for Immune Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Health Product for Immune Sales Share by Manufacturers (2018-2024)
Table 18. Global Health Product for Immune Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Health Product for Immune Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Health Product for Immune, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Health Product for Immune Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Health Product for Immune Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Health Product for Immune by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Health Product for Immune as of 2022)
Table 24. Global Key Manufacturers of Health Product for Immune, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Health Product for Immune, Product Offered and Application
Table 26. Global Key Manufacturers of Health Product for Immune, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Health Product for Immune Sales by Type (2018-2024) & (K Units)
Table 29. Global Health Product for Immune Sales by Type (2024-2034) & (K Units)
Table 30. Global Health Product for Immune Sales Share by Type (2018-2024)
Table 31. Global Health Product for Immune Sales Share by Type (2024-2034)
Table 32. Global Health Product for Immune Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Health Product for Immune Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Health Product for Immune Revenue Share by Type (2018-2024)
Table 35. Global Health Product for Immune Revenue Share by Type (2024-2034)
Table 36. Health Product for Immune Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Health Product for Immune Price Forecast by Type (2024-2034) & (US$/Unit)
Table 38. Global Health Product for Immune Sales by Application (2018-2024) & (K Units)
Table 39. Global Health Product for Immune Sales by Application (2024-2034) & (K Units)
Table 40. Global Health Product for Immune Sales Share by Application (2018-2024)
Table 41. Global Health Product for Immune Sales Share by Application (2024-2034)
Table 42. Global Health Product for Immune Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Health Product for Immune Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Health Product for Immune Revenue Share by Application (2018-2024)
Table 45. Global Health Product for Immune Revenue Share by Application (2024-2034)
Table 46. Health Product for Immune Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Health Product for Immune Price Forecast by Application (2024-2034) & (US$/Unit)
Table 48. US & Canada Health Product for Immune Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Health Product for Immune Sales by Type (2024-2034) & (K Units)
Table 50. US & Canada Health Product for Immune Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Health Product for Immune Revenue by Type (2024-2034) & (US$ Million)
Table 52. US & Canada Health Product for Immune Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Health Product for Immune Sales by Application (2024-2034) & (K Units)
Table 54. US & Canada Health Product for Immune Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Health Product for Immune Revenue by Application (2024-2034) & (US$ Million)
Table 56. US & Canada Health Product for Immune Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 57. US & Canada Health Product for Immune Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Health Product for Immune Revenue by Country (2024-2034) & (US$ Million)
Table 59. US & Canada Health Product for Immune Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Health Product for Immune Sales by Country (2024-2034) & (K Units)
Table 61. Europe Health Product for Immune Sales by Type (2018-2024) & (K Units)
Table 62. Europe Health Product for Immune Sales by Type (2024-2034) & (K Units)
Table 63. Europe Health Product for Immune Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Health Product for Immune Revenue by Type (2024-2034) & (US$ Million)
Table 65. Europe Health Product for Immune Sales by Application (2018-2024) & (K Units)
Table 66. Europe Health Product for Immune Sales by Application (2024-2034) & (K Units)
Table 67. Europe Health Product for Immune Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Health Product for Immune Revenue by Application (2024-2034) & (US$ Million)
Table 69. Europe Health Product for Immune Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 70. Europe Health Product for Immune Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Health Product for Immune Revenue by Country (2024-2034) & (US$ Million)
Table 72. Europe Health Product for Immune Sales by Country (2018-2024) & (K Units)
Table 73. Europe Health Product for Immune Sales by Country (2024-2034) & (K Units)
Table 74. China Health Product for Immune Sales by Type (2018-2024) & (K Units)
Table 75. China Health Product for Immune Sales by Type (2024-2034) & (K Units)
Table 76. China Health Product for Immune Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Health Product for Immune Revenue by Type (2024-2034) & (US$ Million)
Table 78. China Health Product for Immune Sales by Application (2018-2024) & (K Units)
Table 79. China Health Product for Immune Sales by Application (2024-2034) & (K Units)
Table 80. China Health Product for Immune Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Health Product for Immune Revenue by Application (2024-2034) & (US$ Million)
Table 82. Asia Health Product for Immune Sales by Type (2018-2024) & (K Units)
Table 83. Asia Health Product for Immune Sales by Type (2024-2034) & (K Units)
Table 84. Asia Health Product for Immune Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Health Product for Immune Revenue by Type (2024-2034) & (US$ Million)
Table 86. Asia Health Product for Immune Sales by Application (2018-2024) & (K Units)
Table 87. Asia Health Product for Immune Sales by Application (2024-2034) & (K Units)
Table 88. Asia Health Product for Immune Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Health Product for Immune Revenue by Application (2024-2034) & (US$ Million)
Table 90. Asia Health Product for Immune Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 91. Asia Health Product for Immune Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Health Product for Immune Revenue by Region (2024-2034) & (US$ Million)
Table 93. Asia Health Product for Immune Sales by Region (2018-2024) & (K Units)
Table 94. Asia Health Product for Immune Sales by Region (2024-2034) & (K Units)
Table 95. Middle East, Africa and Latin America Health Product for Immune Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Health Product for Immune Sales by Type (2024-2034) & (K Units)
Table 97. Middle East, Africa and Latin America Health Product for Immune Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Health Product for Immune Revenue by Type (2024-2034) & (US$ Million)
Table 99. Middle East, Africa and Latin America Health Product for Immune Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Health Product for Immune Sales by Application (2024-2034) & (K Units)
Table 101. Middle East, Africa and Latin America Health Product for Immune Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Health Product for Immune Revenue by Application (2024-2034) & (US$ Million)
Table 103. Middle East, Africa and Latin America Health Product for Immune Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 104. Middle East, Africa and Latin America Health Product for Immune Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Health Product for Immune Revenue by Country (2024-2034) & (US$ Million)
Table 106. Middle East, Africa and Latin America Health Product for Immune Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Health Product for Immune Sales by Country (2024-2034) & (K Units)
Table 108. Amway Company Information
Table 109. Amway Description and Major Businesses
Table 110. Amway Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Amway Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Amway Recent Developments
Table 113. Suntory Company Information
Table 114. Suntory Description and Major Businesses
Table 115. Suntory Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Suntory Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Suntory Recent Developments
Table 118. GNC Company Information
Table 119. GNC Description and Major Businesses
Table 120. GNC Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. GNC Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. GNC Recent Developments
Table 123. INFINITUS Company Information
Table 124. INFINITUS Description and Major Businesses
Table 125. INFINITUS Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. INFINITUS Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. INFINITUS Recent Developments
Table 128. Herbalife Nutrition Company Information
Table 129. Herbalife Nutrition Description and Major Businesses
Table 130. Herbalife Nutrition Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Herbalife Nutrition Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Herbalife Nutrition Recent Developments
Table 133. USANA Health Sciences, Inc. Company Information
Table 134. USANA Health Sciences, Inc. Description and Major Businesses
Table 135. USANA Health Sciences, Inc. Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. USANA Health Sciences, Inc. Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. USANA Health Sciences, Inc. Recent Developments
Table 138. PERFECT Company Information
Table 139. PERFECT Description and Major Businesses
Table 140. PERFECT Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. PERFECT Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. PERFECT Recent Developments
Table 143. Nestlé SA Company Information
Table 144. Nestlé SA Description and Major Businesses
Table 145. Nestlé SA Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Nestlé SA Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Nestlé SA Recent Developments
Table 148. H&H Group Company Information
Table 149. H&H Group Description and Major Businesses
Table 150. H&H Group Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. H&H Group Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. H&H Group Recent Developments
Table 153. China New Era Group Company Information
Table 154. China New Era Group Description and Major Businesses
Table 155. China New Era Group Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. China New Era Group Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. China New Era Group Recent Developments
Table 158. By-health Company Information
Table 159. By-health Description and Major Businesses
Table 160. By-health Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. By-health Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. By-health Recent Developments
Table 163. Black Mores Company Information
Table 164. Black Mores Description and Major Businesses
Table 165. Black Mores Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Black Mores Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Black Mores Recent Developments
Table 168. Glanbia Plc Company Information
Table 169. Glanbia Plc Description and Major Businesses
Table 170. Glanbia Plc Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Glanbia Plc Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Glanbia Plc Recent Developments
Table 173. Nature’s Company Information
Table 174. Nature’s Description and Major Businesses
Table 175. Nature’s Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Nature’s Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Nature’s Recent Developments
Table 178. Real Nutriceutical Company Information
Table 179. Real Nutriceutical Description and Major Businesses
Table 180. Real Nutriceutical Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Real Nutriceutical Health Product for Immune Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Real Nutriceutical Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Health Product for Immune Distributors List
Table 186. Health Product for Immune Customers List
Table 187. Health Product for Immune Market Trends
Table 188. Health Product for Immune Market Drivers
Table 189. Health Product for Immune Market Challenges
Table 190. Health Product for Immune Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Health Product for Immune Product Picture
Figure 2. Global Health Product for Immune Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Health Product for Immune Market Share by Type in 2022 & 2034
Figure 4. Capsule/Pills Product Picture
Figure 5. Powder Product Picture
Figure 6. Liquid Product Picture
Figure 7. Global Health Product for Immune Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Health Product for Immune Market Share by Application in 2022 & 2034
Figure 9. Children/Teenagers
Figure 10. Men
Figure 11. Adults
Figure 12. The Elderly
Figure 13. Health Product for Immune Report Years Considered
Figure 14. Global Health Product for Immune Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Health Product for Immune Revenue 2018-2034 (US$ Million)
Figure 16. Global Health Product for Immune Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Health Product for Immune Revenue Market Share by Region (2018-2034)
Figure 18. Global Health Product for Immune Sales 2018-2034 ((K Units)
Figure 19. Global Health Product for Immune Sales Market Share by Region (2018-2034)
Figure 20. US & Canada Health Product for Immune Sales YoY (2018-2034) & (K Units)
Figure 21. US & Canada Health Product for Immune Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Health Product for Immune Sales YoY (2018-2034) & (K Units)
Figure 23. Europe Health Product for Immune Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Health Product for Immune Sales YoY (2018-2034) & (K Units)
Figure 25. China Health Product for Immune Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Asia (excluding China) Health Product for Immune Sales YoY (2018-2034) & (K Units)
Figure 27. Asia (excluding China) Health Product for Immune Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Health Product for Immune Sales YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Health Product for Immune Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Health Product for Immune Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Health Product for Immune in the World: Market Share by Health Product for Immune Revenue in 2022
Figure 32. Global Health Product for Immune Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Health Product for Immune Sales Market Share by Type (2018-2034)
Figure 34. Global Health Product for Immune Revenue Market Share by Type (2018-2034)
Figure 35. Global Health Product for Immune Sales Market Share by Application (2018-2034)
Figure 36. Global Health Product for Immune Revenue Market Share by Application (2018-2034)
Figure 37. US & Canada Health Product for Immune Sales Market Share by Type (2018-2034)
Figure 38. US & Canada Health Product for Immune Revenue Market Share by Type (2018-2034)
Figure 39. US & Canada Health Product for Immune Sales Market Share by Application (2018-2034)
Figure 40. US & Canada Health Product for Immune Revenue Market Share by Application (2018-2034)
Figure 41. US & Canada Health Product for Immune Revenue Share by Country (2018-2034)
Figure 42. US & Canada Health Product for Immune Sales Share by Country (2018-2034)
Figure 43. U.S. Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Health Product for Immune Sales Market Share by Type (2018-2034)
Figure 46. Europe Health Product for Immune Revenue Market Share by Type (2018-2034)
Figure 47. Europe Health Product for Immune Sales Market Share by Application (2018-2034)
Figure 48. Europe Health Product for Immune Revenue Market Share by Application (2018-2034)
Figure 49. Europe Health Product for Immune Revenue Share by Country (2018-2034)
Figure 50. Europe Health Product for Immune Sales Share by Country (2018-2034)
Figure 51. Germany Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 52. France Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 53. U.K. Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 54. Italy Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 55. Russia Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 56. China Health Product for Immune Sales Market Share by Type (2018-2034)
Figure 57. China Health Product for Immune Revenue Market Share by Type (2018-2034)
Figure 58. China Health Product for Immune Sales Market Share by Application (2018-2034)
Figure 59. China Health Product for Immune Revenue Market Share by Application (2018-2034)
Figure 60. Asia Health Product for Immune Sales Market Share by Type (2018-2034)
Figure 61. Asia Health Product for Immune Revenue Market Share by Type (2018-2034)
Figure 62. Asia Health Product for Immune Sales Market Share by Application (2018-2034)
Figure 63. Asia Health Product for Immune Revenue Market Share by Application (2018-2034)
Figure 64. Asia Health Product for Immune Revenue Share by Region (2018-2034)
Figure 65. Asia Health Product for Immune Sales Share by Region (2018-2034)
Figure 66. Japan Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 67. South Korea Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 68. China Taiwan Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 69. Southeast Asia Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 70. India Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Health Product for Immune Sales Market Share by Type (2018-2034)
Figure 72. Middle East, Africa and Latin America Health Product for Immune Revenue Market Share by Type (2018-2034)
Figure 73. Middle East, Africa and Latin America Health Product for Immune Sales Market Share by Application (2018-2034)
Figure 74. Middle East, Africa and Latin America Health Product for Immune Revenue Market Share by Application (2018-2034)
Figure 75. Middle East, Africa and Latin America Health Product for Immune Revenue Share by Country (2018-2034)
Figure 76. Middle East, Africa and Latin America Health Product for Immune Sales Share by Country (2018-2034)
Figure 77. Brazil Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 78. Mexico Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 79. Turkey Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 80. Israel Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 81. GCC Countries Health Product for Immune Revenue (2018-2034) & (US$ Million)
Figure 82. Health Product for Immune Value Chain
Figure 83. Health Product for Immune Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed